Scandinavian cardiovascular journal : SCJ
-
Scand. Cardiovasc. J. · Feb 2009
Randomized Controlled Trial Multicenter StudyRationale and design of the Randomized Intervention with CPAP in Coronary Artery Disease and Sleep Apnoea--RICCADSA trial.
Obstructive sleep apnoea (OSA) is common in coronary artery disease (CAD) and a possible cause of increased mortality. To date, there is a lack of randomized controlled trials to draw the conclusion that all CAD patients should be investigated for OSA and subsequently be treated with continuous positive airway pressure (CPAP). ⋯ The RICCADSA trial will contribute to defining the impact of CPAP on prognosis of CAD patients with OSA.